期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

PET显像技术在阿尔茨海默病诊断中的应用 被引量：3

Application of PET imaging in the diagnosis of Alzheimer's disease
下载PDF
导出
摘要 阿尔茨海默病(AD)是老年期痴呆最常见类型。目前,分子影像学在AD的基础与临床研究中发挥着重要的作用。PET功能显像可通过各种显像剂敏感、特异性地反映AD的病理生理学改变,笔者将重点介绍^(18)F-FDG显像剂和淀粉样蛋白显像剂在AD中的应用,详细阐述PET显像在AD病因学研究、早期诊断、鉴别诊断、疾病转归和药物治疗中的作用。 Alzheimer＇s disease is the most common cause of dementia in the current elderly population. Molecular imaging plays an important role in the basic and clinical research of Alzheimer＇s disease. PET can detect pathophysiological changes in Alzheimer＇s disease with different radiotracers. This paper will focus on evaluating the value of ^18F-FDG and amyloid PET imaging in Alzheimer＇s disease, and describe in detail the role of PET imaging in the research of etiology, early diagnosis, differential diagnosis, prognosis and medical treatment of Alzheimer＇s disease.
作者 陶霖 郑东明
机构地区 中国医科大学附属盛京医院神经内科
出处 《中国临床医学影像杂志》 CAS 北大核心 2016年第5期367-369,共3页 Journal of China Clinic Medical Imaging
关键词 阿尔茨海默病 正电子发射断层显像术 Alzheimer diseases Positron-emission tomography
分类号 R749.16 [医药卫生—神经病学与精神病学] R817.4 [医药卫生—影像医学与核医学]
  • 相关文献

参考文献33

  • 1Caroli AI, Prestia A, Chen K, et al. Summary metrics to assess Alzheimer disease-related hypometabolic pattern with JSF-FDG PET: head-to head comparison [J]. J Nucl Med, 2012, 53(4): 592-600.
  • 2Klunk WE, Engler H, Nordberg A, et al, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B [J]. Ann Neurol, 2004, 55(5): 306-319.
  • 3Buckner RL, Snyder AZ, Shannon B J, et al. Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory [J]. J Neurosci, 2005, 25(34): 7709-7717.
  • 4Landau SM, Harvey D, Madison CM, et al. Associations between cognitive, functionaL, and FDG-PET measures of decline in AD and MCI[J]. Neurobiol Aging, 2011, 32(7): 1207-1218.
  • 5左传涛,刘永昌,管一晖,赵军,林祥通.年龄对脑葡萄糖代谢的影响[J].中国医学计算机成像杂志,2001,7(3):204-206. 被引量：4
  • 6Herbolz K, Sahnon E, Perani JC, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multi- center FDG PET[J]. Neuroimage, 2002, 17(1): 302-316.
  • 7Ishii K, Sasaki M, Kitagaki H, et al. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease [J]. J Nucl Med, 1997, 38(6): 925-928.
  • 8Dubois B, Feldman HH, Jacova C, et al. Advaneing research di- agnostic criteria for Alzheimer's disease: the IWG-2 criteria[J]. Lancet Neurol, 2014, 13(6): 614-629.
  • 9Mega MS, Cummings JL, O'Connor SM, et al. Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease [J]. Neuropsyehiatry Neuropsyehol Behav Neurnl, 2001, 14(1): 63- 68.
  • 10Pagani M, Dessi B, Morberlli S, et al. MCI patients declining and declining at mid-term follow-up: FDG-PET findings[J]. Curt" Alzheimer Res, 2010, 7(4): 287-294.

二级参考文献51

  • 1吴义根,李可.SPM软件包数据处理原理简介——第二部分:应用于PET及fMRI[J].中国医学影像技术,2004,20(11):1772-1775. 被引量：21
  • 2苏亮,左传涛,管一晖,赵军,施慎逊.^(18)F-FDG PET脑显像用于恶性肿瘤患者抑郁分析[J].中华核医学杂志,2005,25(3):159-161. 被引量：6
  • 3Lowe J. Establishing a pathological diagnosis in degenerative dementias. Brain Pathol, 1998, 8: 403-406.
  • 4Aarsland D, Andersen K, Larsen JP, et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol, 2003,60 : 387-392.
  • 5Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology,1998, 51 : 1546-1554.
  • 6McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) : report of the consortium on DLB international workshop. Neurology, 1996,47 : 1113-1124.
  • 7Mielke R, Kessler J, Szelies B, et al. Normal and pathological aging-findings of positron-emission-tomography. J Neural Transm, 1998, 105 : 821-37.
  • 8Herholz K, Salmon E, Perani D, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. NeuroImage, 2002, 17 : 302-316.
  • 9Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementias. J Neuro Neurosurg Psychiatry, 1994, 57: 416-418.
  • 10Jeong Y, Cho SS, Park JM, et al. ^18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. J Nucl Med, 2005, 46 : 233-239.

共引文献18

同被引文献12

引证文献3

二级引证文献1

中国临床医学影像杂志
2016年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部